# Effect of Obesity on Immune Response to Pneumovax 23

> **NCT02471014** · — · COMPLETED · sponsor: **University of Florida** · enrollment: 50 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Pneumovax 23
- **OTHER:** Blood tests
- **OTHER:** Questionnaires

## Key facts

- **NCT ID:** NCT02471014
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2019-03
- **Final completion:** 2019-05-16
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2020-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02471014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02471014, "Effect of Obesity on Immune Response to Pneumovax 23". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02471014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*